DAVITA INC. Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares
DAVITA INC. (DVA) reported Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares of 0 shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares · last filed 2021-02-12
- DAVITA INC. incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2015-03-31 was 2.19M shares.
- DAVITA INC. incremental common shares attributable to dilutive effect of contingently issuable shares for fiscal 2020 was 0.00 shares.
- DAVITA INC. incremental common shares attributable to dilutive effect of contingently issuable shares for fiscal 2019 was 0.00 shares, a 100.00% decline from fiscal 2018.
- DAVITA INC. incremental common shares attributable to dilutive effect of contingently issuable shares for fiscal 2018 was 1.10M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 3 month | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 12 month |
|---|---|---|
| 2020-12-31 | 0.00 shares 10-K · filed 2021-02-12 | |
| 2019-12-31 | 0.00 shares 10-K · filed 2021-02-12 | |
| 2018-12-31 | 1.10M shares 10-K · filed 2021-02-12 | |
| 2015-03-31 | 2.19M shares 10-Q · filed 2016-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |